ARSTIFEN®
PHARMACEUTICAL FORM:
Effervescent tablets
ATC class:
Urinary concrement solvents.
Active substance:
citric acid anhydrous, trisodium citrate anhydrous, potassium hydrocarbonate
Composition:
1 tablet contains citric acid anhydrous 1197 mg; trisodium citrate anhydrous 835.5 mg; potassium hydrocarbonate 967.5 mg
Indications for use:
Arstifen® is used for the treatment of urinary stone disease with the purpose of: alkalization of urine in patients with urate stones, in the presence of concomitant calcium stones or without them;
metaphysics of calcium-oxalate concretions (prevention of re-formation of new stones and/or growth of residual fragments)
